{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:37:21Z","timestamp":1769600241575,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":5064,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1038\/modpathol.2008.207","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T10:01:59Z","timestamp":1231495319000},"page":"476-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas"],"prefix":"10.1016","volume":"22","author":[{"given":"Cecile","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bourgau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Hirschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juerg","family":"Schwaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Went","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano A","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2008.207_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gde.2006.12.009","article-title":"Jak2: normal function and role in hematopoietic disorders","volume":"17","author":"Ihle","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1038\/modpathol.2008.207_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2008.207_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2008.207_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2008.207_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.leu.2404104","article-title":"A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma","volume":"20","author":"Adelaide","year":"2006","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2008.207_bib6","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1038\/sj.onc.1208850","article-title":"The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1\u2013JAK2 fusion gene","volume":"24","author":"Bousquet","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2008.207_bib7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.humpath.2005.07.020","article-title":"Myelodysplastic\/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case","volume":"36","author":"Heiss","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2008.207_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yexmp.2006.07.004","article-title":"Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the Janus kinase 2 (JAK2) gene","volume":"81","author":"Mark","year":"2006","journal-title":"Exp Mol Pathol"},{"key":"10.1038\/modpathol.2008.207_bib9","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/sj.leu.2403879","article-title":"PCM1\u2013JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation","volume":"19","author":"Murati","year":"2005","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2008.207_bib10","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1158\/0008-5472.CAN-04-4263","article-title":"The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2","volume":"65","author":"Reiter","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2008.207_bib11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2006.06206.x","article-title":"The role of Janus kinases in haemopoiesis and haematological malignancy","volume":"134","author":"Khwaja","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2008.207_bib12","first-page":"549","article-title":"Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2008.207_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bcp.2005.12.017","article-title":"JAK\/STAT signal transduction: regulators and implication in hematological malignancies","volume":"71","author":"Valentino","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/modpathol.2008.207_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/modpathol.2008.207_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/156800906779010227","article-title":"The JAK-STAT pathway: a therapeutic target in hematological malignancies","volume":"6","author":"Ferrajoli","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1038\/modpathol.2008.207_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","article-title":"Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death","volume":"21","author":"Zamo","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2008.207_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2141.2006.06259.x","article-title":"JSI-124 (cucurbitacin I) inhibits Janus kinase-3\/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells","volume":"135","author":"Shi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2008.207_bib18","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","article-title":"Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2008.207_bib19","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.21485","article-title":"Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein","volume":"118","author":"Melzner","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2008.207_bib20","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"key":"10.1038\/modpathol.2008.207_bib21","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2008.207_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10428190500271723","article-title":"JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas","volume":"47","author":"Lee","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2008.207_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.leu.2404036","article-title":"Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma","volume":"20","author":"Melzner","year":"2006","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2008.207_bib24","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1038\/modpathol.2008.207_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.11702","article-title":"Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma","volume":"93","author":"Tzankov","year":"2008","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2008.207_bib26","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1158\/1078-0432.CCR-05-2135","article-title":"Diffuse large B-cell lymphoma with over-expression of cyclin E substantiates poor standard treatment response and inferior outcome","volume":"12","author":"Tzankov","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2008.207_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/modpathol.3800276","article-title":"Aberrant expression of cell cycle regulators in Hodgkin and Reed\u2013Sternberg cells of classical Hodgkin lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2008.207_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.exger.2005.06.011","article-title":"Tissue microarray technology: principles, pitfalls and perspectives\u2013lessons learned from hematological malignancies","volume":"40","author":"Tzankov","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1038\/modpathol.2008.207_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/aje\/kwk011","article-title":"Receiver operating characteristic curve inference from a sample with a limit of detection","volume":"165","author":"Perkins","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1038\/modpathol.2008.207_bib30","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.180.7.4805","article-title":"STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation","volume":"180","author":"Diehl","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2008.207_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni1172","article-title":"STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression","volume":"6","author":"Scheeren","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1038\/modpathol.2008.207_bib32","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.1038\/modpathol.2008.207_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2008.207_bib34","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1038\/modpathol.2008.207_bib35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/sj.leu.2403750","article-title":"STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis","volume":"19","author":"Holtick","year":"2005","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2008.207_bib36","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0002-9440(10)63742-X","article-title":"Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations","volume":"164","author":"Zettl","year":"2004","journal-title":"Am J Pathol"},{"issue":"s5","key":"10.1038\/modpathol.2008.207_bib37","first-page":"43","article-title":"A novel t(4;9)(q21;p24) fuses SEC13A to JAK2 in nodular sclerosis Hodgkin Lymphoma","volume":"92","author":"Van Roosbroeck","year":"2007","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2008.207_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molmed.2006.11.001","article-title":"The STAT3 oncogene as a predictive marker of drug resistance","volume":"13","author":"Barr\u00e9","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1038\/modpathol.2008.207_bib39","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0002-9440(10)63525-0","article-title":"Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology","volume":"163","author":"Mandell","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2008.207_bib40","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2008207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2008207","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522202556X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522202556X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2008207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:00:44Z","timestamp":1760230844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522202556X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S089339522202556X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2008.207","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2008.207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}